Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine

Journal of Neurochemistry

Volumn 122, Issue 5, 2012, Pages 995-1009

  Kelly, Kimberly A ^a   Miller, Diane B ^a   Bowyer, John F ^b   O'Callaghan, James P ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

glucocorticoids; methamphetamine; microglial activation; neuroinflammation; neurotoxicity; stress

Indexed keywords

CHEMOKINE; CORTICOSTERONE; CYTOKINE; MESSENGER RNA; METHAMPHETAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTIC HYPERTROPHY; ASTROCYTOSIS; CHEMOSENSITIZATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG EXPOSURE; DRUG RESPONSE; DRUG TREATMENT FAILURE; FRONTAL CORTEX; HIPPOCAMPUS; HYPERTROPHY; MALE; MICROGLIA; MOUSE; NERVE CELL LESION; NERVE CELL STIMULATION; NERVE ENDING; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT DURATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOSTERONE; CYTOKINES; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTROCHEMICAL TECHNIQUES; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIAL FIBRILLARY ACIDIC PROTEIN; LECTINS; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICROGLIA; TIME FACTORS; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

MUS;

EID: 84865322065     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07864.x     Document Type: Article

References (83)

1. Bauer S., Kerr B. J., and, Patterson P. H., (2007) The neuropoietic cytokine family in development, plasticity, disease and injury. Neuroscience 8, 221-232. (Pubitemid 46294661)
2. Block M.L., Zecca L., and, Hong J.S., (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69. (Pubitemid 46011999)
3. Bowers S. L., Bilbo S.D., Dhabhar F. S., and, Nelson R. J., (2008) Stressor-specific alterations in corticosterone and immune responses in mice. Brain Behav. Immun. 22, 105-113. (Pubitemid 350216366)
4. Bowyer J. F., and, Ali S., (2006) High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 60, 521-532. (Pubitemid 44537085)
5. Bowyer J.F, and, Holson R. R., (1995) Methamphetamine and amphetamine neurotoxicity, in Handbook of Neurotoxicity (, Chang L. W., and, Dyer R. S,., eds), pp. 845-870. Marcel Dekker, New York.
6. Bowyer J.F., Scallet A.C., Holson R.R., Lipe G.W., Slikker Jr W., and, Ali S.F., (1991) Interactions of MK-801 with glutamate-, glutamine- and methamphetamine-evoked release of [3H]dopamine from striatal slices. J. Pharmacol. Exp. Ther. 257, 262-270.
7. Bowyer J.F., Tank A.W., Newport G.D., Slikker Jr W., Ali S.F., and, Holson R.R., (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260, 817-824.
8. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker Jr W., and, Holson R.R., (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268, 1571-1580. (Pubitemid 24100380)
9. Bowyer J.F., Peterson S.L., Rountree R.L., Tor-Agbidye J., and, Wang G.J., (1998) Neuronal degeneration in rat forebrain resulting from D-amphetamine-induced convulsions is dependent on seizure severity and age. Brain Res. 809, 77-90. (Pubitemid 29003428)
10. Bowyer J.F., Harris A.J., Delongchamp R.R., Jakab R.L., Miller D.B., Little A.R., and, O'Callaghan J.P., (2004a) Selective changes in gene expression in cortical regions sensitive to amphetamine during the neurodegenerative process. Neurotoxicology 25, 555-572. (Pubitemid 38739113)
11. Bowyer J.F., Delongchamp R.R., and, Jakab R.L., (2004b) Glutamate N-methyl-D-aspartate and dopamine receptors have contrasting effects on the limbic versus the somatosensory cortex with respect to amphetamine-induced neurodegeneration. Brain Res. 1030, 234-236.
12. Bowyer J.F., Thomas M., Schmued L.C., and, Ali S.F., (2008) Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures, and the blood-brain barrier. Ann. N. Y. Acad. Sci. 1139, 127-139.
13. Brown J.M., Quinton M.S., and, Yamamoto B.K., (2005) Methamphetamine- induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite. J. Neurochem. 95, 429-436. (Pubitemid 41457511)
14. Cappon G.D., Broening H.W., Pu C., Morford L., and, Vorhees C.V., (1996) alpha-Phenyl-N-tert-butyl nitrone attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia. Synapse 24, 173-181. (Pubitemid 26339310)
15. De Pablos R. M., Villaran R. F., Arguelles S., Herrera A. J., Venero J. L., Ayala A., Cano J., and, Machado A., (2006) Stress increases vulnerability to inflammation in the rat prefrontal cortex. J. Neurosci. 26, 5709-5719. (Pubitemid 44315262)
16. Dhabhar F.S., (2009) Enhancing versus suppressive effects of stress on immune function: implicatons for immuosprotection and immunopathology. NeuroImmunoModulation 16, 300-317.
17. Eisch A. J., Schmued L. C., and, Marshall J. F., (1998) Characterizing cortical neuron injury with fluoro-jade labeling after a neurotoxic regimen of methamphetamine. Synapse 30, 329-333. (Pubitemid 28447180)
18. Ellinwood Jr E. H., and, Escalante O., (1970) Behavior and histopathological findings during chronic methedrine intoxication. Biol. Psychiatry 2, 27-39.
19. Eng L.F., Ghirnikar R.S., and, Lee Y.L., (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 25, 1439-1451.
20. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., and, Hanson G.R., (2007) New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47, 681-698.
21. Frank M. G., Barrata M. V., Sprunger D. B., Watkins L. R., and, Maier S. F., (2006) Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav. Immun. 21, 47-59. (Pubitemid 44854445)
22. Frank M. G., Miguel Z. D., Watkins L. R., and, Maier S. F., (2010) Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav. Immun. 24, 19-30.
23. Frank M. G., Watkins L. R., and, Maier S. F., (2011) Stress- and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stress-induced vulnerability to drugs of abuse. Brain Behav. Immun. 25, S21-S28.
24. Graeber M.B., and, Streit W.J., (2010) Microglia: biology and pathology. Acta Neuropathol. 119, 89-105.
25. Gudelsky G. A., and, Yamamoto B. K., (2008) Actions of 3,4-methylene-dioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacol. Biochem. Behav. 90, 198-207. (Pubitemid 351787346)
26. Hotchkiss A. J., Morgan M. E., and, Gibb J.W., (1979) The long-term effects of multiple doses of methamphetamine in neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci. 25, 1373-1379.
27. Jackson-Lewis V., and, Przedborski S., (2007) Protocol for the MPTP mouse model of Parkinson's disease. Nat. Protoc. 2, 141-151. (Pubitemid 47044700)
28. Johnson J. D., O'Connor K. A., Deak T., Stark M., Watkins L. R., and, Maier S. F., (2002) Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav. Immun. 16, 461-476. (Pubitemid 35346208)
29. Johnson E. A., O'Callaghan J.P., and, Miller D.B., (2004) Brain concentrations of d-MDMA are increased after stress. Psychopharmacology 173, 278-286. (Pubitemid 38703801)
30. Kelly K. A., Miller D. B., Lasley S. M., and, O'Callaghan J. P., (2011) Chronic Exposure to Glucocorticoids, Pb and DEET Primes the Neuroinflammatory Response to the Nerve Agent DFP in a Potential Model for Gulf War Illness. Program No. 676.01. 2011 Neuroscience Meeting Planner. Society for Neuroscience Abstracts, Washington, DC.
31. Kraft A. D., and, Harry G.J., (2011) Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. Int. J. Environ. Res. Public Health 8, 2980-3018.
32. Krasnova I. N., and, Cadet J. L., (2009) Methamphetamine toxicity and messengers of death. Brain Res. Rev. 60, 379-407.
33. Kreutzberg G. W., (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318. (Pubitemid 26349059)
34. Kuhn D.M., Francescutti-Verbeem D.M., and, Thomas D.M., (2006) Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage. Ann. N. Y. Acad. Sci. 1074, 31-41. (Pubitemid 44532808)
35. Kwon M. S., Seo Y. S., Lee J. K., Jung J. S., Jang J. E., Park S. H., and, Suh H. W., (2008) The repeated immobilization stress increases IL-1β immunoreactivites in only neuron, but not astrocyte or microglia in hippocampal CA1 region, striatum and paraventricular nucleus. Neurosci. Lett. 430, 258-263.
36. Ladenheim B., Krasnova I.N., Deng X., Oyler J.M., Polettini A., Moran T.H., Huestis M.A., and, Cadet J.L., (2000) Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol. Pharmacol. 58, 1247-1256.
37. LaVoie M. J., Card J. P., and, Hastings T. G., (2004) Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp. Neurol. 187, 47-57. (Pubitemid 38470011)
38. Mark K.A., Soghomonian J.J., and, Yamamoto B.K., (2004) High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J. Neurosci. 24, 11449-11456. (Pubitemid 39658280)
39. Martin P. M., and, O'Callaghan J. P., (1995) A direct comparison of GFAP immunocytochemistry and GFAP concentration in various regions of ethanol-fixed rat and mouse brain. J. Neurosci. Methods 58, 181-192.
40. McCoy M.K., and, Tansey M.G., (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflamm. 17, 5-45.
41. Miller D. B., and, O'Callaghan J. P., (1994) Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270, 752-760. (Pubitemid 24271392)
42. Munhoz C. D., Lepsch L. B., Kawamoto E. M., Malta M. B., Lima Lde S., Avellar M. C., Sapolsky R. M., and, Scavone C., (2006) Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J. Neurosci. 26, 3813-3820.
43. Munhoz C. D., Sorrells S. F., Caso J. R., Scavone C., and, Sapolsky R. M., (2010) Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner. J. Neurosci. 30, 13690-13698.
44. Nair A., and, Bonneau R. H., (2006) Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J. Neuroimmunol. 171, 72-85. (Pubitemid 41832279)
45. Nash J.F., and, Yamamoto B.K., (1992) Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581, 237-243.
46. Nishi A., Kuroiwa M., Miller D., et al. (2008) Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J. Neurosci. 28, 10460-10471.
47. Norenberg M. D., (2005) The reactive astrocyte, in The Role of Glia in Neurotoxicity (, Aschner M, and, Costa LG, eds), pp. 73-92. CRC Press, Boca Raton, FL.
48. O'Callaghan J. P., (1991) Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 13, 275-281.
49. O'Callaghan J. P., (2002) Measurement of glial fibrillary acidic protein, pp. 12.8.1-12.8.12. John Wiley & Sons, New York.
50. O'Callaghan J. P., and, Miller D. B., (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270, 741-751. (Pubitemid 24271391)
51. O'Callaghan J.P., and, Miller D.B., (2005) Neurotoxic effects of substituted amphetamines in rats and mice, in Handbook of Neurotoxicology (, Massaro E.J., ed.), pp. 269-301. Human Press, Inc., Totowa, NJ.
52. O'Callaghan J. P., and, Sriram K., (2005) Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opin. Drug Saf. 4, 433-442. (Pubitemid 40723718)
53. O'Callaghan J. P., Miller D. B., and, Reinhard Jr J. F., (1990) Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Res. 521, 73-80. (Pubitemid 20208736)
54. O'Callaghan J.P., Brinton R.E., and, McEwen B.S., (1991) Glucocoritcoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenalectomized rats but do not affect its expression following brain injury. J. Neurochem. 57, 860-869.
55. O'Callaghan J.P., Sriram K., and, Miller D.B., (2008) Defining "Neuroinflammation": Lessons from MPTP- and Methamphetamine-Induced Neurotoxicity. Annal. NY Acad. Sci. 1139, 318-330.
56. Prinz M., Priller J., Sisodia S. S., and, Ransohoff R.M., (2011) Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 14, 1227-12235.
57. Quan N., Stern E.L., Whiteside M.B., and, Herkenham M., (1999) Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J. Neuroimmunol. 93, 72-80. (Pubitemid 29051552)
58. Riddle E. L., Fleckenstein A. E., and, Hanson G. R., (2006) Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. AAPS J. 8, E413-E418. (Pubitemid 43964450)
59. Schmued L. C., and, Bowyer J. F., (1997) Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res. 759, 135-140. (Pubitemid 27286352)
60. Seiden L.S., Fischuman M.W., and, Schuster C.R., (1976) Long-term methamphetamine induced in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1, 215-229.
61. Silva A. P., Martins T., Baptista S., GonÃalves J., Agasse F., and, Malva J. O., (2010) Brain Injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier.Curr. Drug Abuse Rev. 3, 239-354.
62. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., and, Klenk D. C., (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85. (Pubitemid 16258399)
63. Sofroniew M.V., (2005) Reactive astrocytes in neural repair and protection. Neuroscientist 11, 400-407. (Pubitemid 41339226)
64. Sofroniew M.V., (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32, 638-647.
65. Sorrells S. F., and, Sapolsky R. M., (2007) An inflammatory review of glucocorticoid actions in the CNS. Brain Behav. Immun. 21, 259-272. (Pubitemid 46199119)
66. Sorrells S.F., Caso J.R., Munhoz C.D., and, Sapolsky R.M., (2009) The stressed CNS: when glucocoritcoids aggravate inflammation. Neuron 64, 33-39.
67. Sriram K., and, O'Callaghan J. P., (2007) Divergent roles for tumor necrosis factor-α in the brain. J. Neuroimmune Pharmacol. 2, 140-153.
68. Sriram K., Benkovic S. A., Hebert M. A., Miller D. B., and, O'Callaghan J. P., (2004) Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration. J. Biol. Chem. 279, 19936-19947. (Pubitemid 38623436)
69. Sriram K., Miller D. B., and, O'Callaghan J. P., (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-α. J. Neurochem. 96, 706-718.
70. Streit W. J., (1990) An improved staining method for rat microglial cells using the lectin from Griffoniasimplicifolia (GSA I-B4). J. Histochem. Cytochem. 38, 1683-1686. (Pubitemid 20346979)
71. Streit W.J., (2005) The role of microglia in neurotoxicity, in The Role of Glia in Neurotoxicity (Second Edition) (, Aschner M., and, Costa L. G., eds), pp. 29-40. CRC Press, Boca Raton, FL.
72. Streit W.J., (2010) Microglia activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history. Front. Aging Neurosci. 2, 1-5.
73. Streit W. J., and, Kreutzberg G. W., (1987) Lectin binding by resting and reactive microglia. J. Neurocytol. 16, 249-260. (Pubitemid 17080832)
74. Sugama S., Fujita M., and, Hashimoto M., (2007) Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18. Neuroscience, 146, 1388-1399. (Pubitemid 46694135)
75. Sugama S., Takenouchi T., Fujita M., Conti B., and, Hashimoto M., (2009) Differential microglial activation between acute stress and lipopolysaccharide treatment. J. Neuroimmunol. 207, 24-31.
76. Tansey M., McCoy M.K., and, Frank-Cannon T.C., (2007) Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention Exp. Neurology 208, 1-25. (Pubitemid 47603240)
77. Tata D. A., and, Yamamoto B. K., (2008) Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum. Synapse 62, 325-326.
78. Thomas D.M., Dowgiert J., Geddes T.J., Frtancescutti-Verbeem D., Liu X., and, Kuhn D.M., (2004a) Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci. Lett. 367, 349-354. (Pubitemid 39178611)
79. Thomas D. M., Walker P. D., Benjamins J. A., Geddes T. J., and, Kuhn D. M., (2004b) Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J. Pharmacol. Exp. Ther. 311, 1-7. (Pubitemid 39287777)
80. Watkins L.R., Hutchinson M.R., Ledeboer A., Wieseler-Frank J., Milligan E.D., and, Maier S.F., (2007) glia as the "bad guys": Implications for improving clinical pain control and clinical utility of opioids. Brain Behav. Immun. 21, 131-146. (Pubitemid 46038918)
81. Watkins L.R., Hutchinson M.R., Rice K.C., and, Maier S.F., (2009) The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol. Sci. 30, 581-591.
82. Wohleb E. S., Hanke M. L., Corona A. W., Powell N. D., Stiner L. M., Bailey M. T., Nelson R. J., Godbout J. P., and, Sheridan J. F., (2011) β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 31, 6277-6288.
83. Yamamoto B. K., Moszczynska A., and, Gudelsky G. A., (2010) Amphetamine toxicities: classical and emerging mechanisms. Ann. N. Y. Acad. Sci. 1187, 101-121.